In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Marta Izabela Kaluzna-Oleksy


8 presentations from this speaker

Awareness of heart failure is insufficient in Poland-results from awareness survey

Congress : Heart Failure 2018

  • Session : Chronic Heart Failure - Clinical
  • Speaker : MI Kaluzna-Oleksy (Poznan,PL)

Scenario 2 - Neprilysin inhibitors in heart failure: safety and adverse events

Congress : ESC Congress 2018

  • Session : Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs
  • Speaker : MI Kaluzna-Oleksy (Poznan,PL)

The hypertrophic cardiomyopathy - a particular cause of the heart failure with preserved ejection fraction

Congress : Heart Failure 2018

  • Session : Myocardial Disease - Clinical
  • Speaker : MI Kaluzna-Oleksy (Poznan,PL)

Constrictive pericarditis due to rheumatoid arthritis 6 years follow up

Congress : Heart Failure 2017

  • Session : The very best from clinical cases - 2
  • Speaker : Mi Kaluzna-Oleksy (Poznan,PL)

Pulmonary hypertension due to left heart disease and etiology of heart failure

Congress : Heart Failure 2017

  • Session : Pulmonary hypertension
  • Speaker : Mi Kaluzna-Oleksy (Poznan,PL)

Dyspnea in HF - Is its origin always clear? - Clinical case

Congress : ESC Congress 2016

  • Session : 2016 Heart failure Guidelines in Poland
  • Speaker : Mi Kaluzna-Oleksy (Poznan,PL)

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are